| 20th Oct 2021 5:56 pm |
RNS |
Transaction in Own Shares |
| 19th Oct 2021 6:31 pm |
RNS |
Transaction in Own Shares |
| 19th Oct 2021 7:00 am |
RNS |
Transaction in Own Shares |
| 18th Oct 2021 7:00 am |
RNS |
Transaction in Own Shares |
| 14th Oct 2021 6:27 pm |
RNS |
Transaction in Own Shares |
| 13th Oct 2021 6:22 pm |
RNS |
Transaction in Own Shares |
| 13th Oct 2021 11:36 am |
RNS |
Director Declaration |
| 13th Oct 2021 9:03 am |
RNS |
Holding(s) in Company |
| 12th Oct 2021 6:20 pm |
RNS |
Transaction in Own Shares |
| 12th Oct 2021 2:09 pm |
RNS |
Director/PDMR Shareholding |
| 12th Oct 2021 7:00 am |
RNS |
Transaction in Own Shares |
| 11th Oct 2021 7:41 am |
RNS |
Transaction in Own Shares |
| 8th Oct 2021 7:00 am |
RNS |
Share buyback programme |
| 6th Oct 2021 7:00 am |
RNS |
Board changes |
| 5th Oct 2021 4:44 pm |
RNS |
Holding(s) in Company |
| 30th Sep 2021 4:11 pm |
RNS |
Total Voting Rights |
| 30th Sep 2021 7:45 am |
RNS |
IP Group generates £84m from Oxford Nanopore IPO |
| 27th Sep 2021 12:40 pm |
RNS |
Director/PDMR Shareholding |
| 23rd Sep 2021 3:57 pm |
RNS |
Further re Scrip Dividend |
| 16th Sep 2021 7:08 am |
RNS |
Oxford Nanopore confirms ITF; MoU with Oracle |
| 10th Sep 2021 5:21 pm |
RNS |
Holding(s) in Company |
| 8th Sep 2021 10:53 am |
RNS |
Director/PDMR Shareholding, SAYE scheme |
| 19th Aug 2021 10:41 am |
RNS |
Scrip Dividend Reference Price |
| 12th Aug 2021 5:05 pm |
RNS |
Director Declaration |
| 5th Aug 2021 7:00 am |
RNS |
Half-yearly results |
| 27th Jul 2021 7:03 am |
RNS |
Portfolio company Artios Pharma raises $153m |
| 22nd Jul 2021 11:30 am |
RNS |
Notice of Results |
| 1st Jul 2021 7:00 am |
RNS |
Total Voting Rights |
| 28th Jun 2021 7:30 am |
RNS |
Director/PDMR Shareholding |
| 18th Jun 2021 9:52 am |
RNS |
Director/PDMR Shareholding |
| 17th Jun 2021 7:00 am |
RNS |
Portfolio company Apollo Therapeutics raises $145m |
| 15th Jun 2021 8:00 am |
RNS |
Further re Scrip Dividend |
| 9th Jun 2021 11:29 am |
RNS |
Result of AGM |
| 9th Jun 2021 7:00 am |
RNS |
AGM Statement |
| 7th Jun 2021 7:00 am |
RNS |
Portfolio co Iksuda completes $42m financing round |
| 28th May 2021 3:36 pm |
RNS |
Director/PDMR Shareholding |
| 28th May 2021 10:00 am |
RNS |
Joint venture with China Everbright to launch fund |
| 27th May 2021 7:00 am |
RNS |
Portfolio co Pulmocide completes $92m Series C |
| 26th May 2021 2:44 pm |
RNS |
Update on AGM |
| 20th May 2021 10:01 am |
RNS |
Scrip Dividend Reference Price |
